nach oben

Current Cardiology Reports

Erschienen in:

24.07.2023 | Psychological Aspects of Cardiovascular Diseases (IM Kronish, Section Editor)

Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD

verfasst von: Sears S. F., Harrell R., Sorrell A., Jordan E., Anthony S., Hashmath Z., Nekkanti R.

Erschienen in: Current Cardiology Reports | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This paper reviews the unique processes and treatments of post-traumatic stress in implantable cardioverter-defibrillator (ICD) patients and posits specific clinical management recommendations.

Recent Findings

PTSD is a common presenting problem for a prospective ICD patient and is a common response to ICD shocks. Approximately 32% of patients with sudden cardiac arrest report significant PTSD symptoms. Following ICD shock, approximately 20% experience PTSD from the shocks. Regardless, PTSD can interrupt and undermine clinical management from a cardiologist perspective and create significant disturbance in patients and families. Few cardiology clinics are outfitted to effectively manage psychological distress, in general, and PTSD, in particular.

Summary

Effective management of PTSD patients can be achieved with both direct care in the cardiac clinic, as well as indirect care via multidisciplinary consultation and expertise. The importance of emotional validation, return to physical activity, and family engagement is emphasized in current management.

• Princip M, Ledermann K, von Känel R. Posttraumatic stress disorder as a consequence of acute cardiovascular disease. Curr Cardiol Rep. 2023;25(6):455–65. https://doi.org/10.1007/s11886-023-01870. This recent paper reviews the clinical considerations of posttraumatic stress in patients undergoing acute cardiac care.CrossRefPubMedPubMedCentral

•• Januszkiewicz Ł, Barra S, Providencia R, et al. Long-term quality of life and acceptance of implantable cardioverter-defibrillator therapy: results of the European Heart Rhythm Association survey. Europace. 2022;24(5):860–7. https://doi.org/10.1093/europace/euac011. This recent large-scale European survey of ICD patients provides contemporary patient views of their experiences in living with an ICD.CrossRefPubMed

Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2018;15(10):e73–189. https://doi.org/10.1016/j.hrthm.2017.10.036.CrossRefPubMed

Paratz ED, Rowsell L, Zentner D, et al. Cardiac arrest and sudden cardiac death registries: a systematic review of global coverage. Open Heart. 2020;7(1):e001195. https://doi.org/10.1136/openhrt-2019-001195.

Waks JW, Buxton AE. Risk stratification for sudden cardiac death after myocardial infarction. Annu Rev Med. 2018;69:147–64. https://doi.org/10.1146/annurev-med-041316-090046.CrossRefPubMed

Soejima K, Stevenson WG. Ventricular tachycardia associated with myocardial infarct scar: a spectrum of therapies for a single patient. Circulation. 2002;106(2):176–9. https://doi.org/10.1161/01.cir.0000019361.34897.75.CrossRefPubMed

Sears SF, Whited A, Volosin KJ. Enhancing patient care by estimation and discussion of risk for ICD shock. Pacing Clin Electrophysiol. 2015;38(1):1–7. https://doi.org/10.1111/pace.12547.CrossRefPubMed

van Rees JB, Borleffs CJ, de Bie MK, et al. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. 2011;57(5):556–62. https://doi.org/10.1016/j.jacc.2010.06.059.CrossRefPubMed

Wu KC, Wongvibulsin S, Tao S, et al. Baseline and dynamic risk predictors of appropriate implantable cardioverter defibrillator therapy. J Am Heart Assoc. 2020;9(20):e017002. https://doi.org/10.1161/JAHA.120.017002.

10.

Perini AP, Kutyifa V, Veazie P, et al. Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: a MADIT-RIT substudy. Am Heart J. 2017;189:75–84. https://doi.org/10.1016/j.ahj.2017.03.009.CrossRefPubMed

11.

Diagnostic and statistical manual of mental disorders: DSM-5-TR. American Psychiatric Association Publishing; 2022.

12.

Bryant RA. Post-traumatic stress disorder: a state-of-the-art review of evidence and challenges. World Psychiatry. 2019;18(3):259–69. https://doi.org/10.1002/wps.20656.CrossRefPubMedPubMedCentral

13.

de Ornelas Maia AC, Braga Ade A, Paes F, et al. Comorbidity of depression and anxiety: association with poor quality of life in type 1 and 2 diabetic patients. Clin Pract Epidemiol Ment Health. 2013;9:136–41. https://doi.org/10.2174/1745017901309010136.CrossRefPubMedPubMedCentral

14.

Miranda J, Stiles M, Lever N, Mahadevan H. Prevalence of depression and anxiety among patients with cardiac implantable electronic device (CIED). Heart Lung Circ. 2018;27:S13–4.CrossRef

15.

Rosman L, Ford J, Whited A, et al. Compound risk: History of traumatic stress predicts posttraumatic stress disorder symptoms and severity in sudden cardiac arrest survivors. Eur J Cardiovasc Nurs. 2016;15(5):372–9. https://doi.org/10.1177/1474515115587165.CrossRefPubMed

16.

• Storer B, Kershaw KA, Braund TA, et al. Global prevalence of anxiety in adult cardiology outpatients: a systematic review and meta-analysis. Curr Probl Cardiol. 2023;101877. https://doi.org/10.1016/j.cpcardiol.2023.101877. This recent review provides a recent summation regarding the overall base rates of psychological distress across subgroups of cardiac patients.

17.

van der Lingen ACJ, Rijnierse MT, Hooghiemstra AM, et al. The link between cardiac status and depression and anxiety in implantable cardioverter defibrillator patients: design and first results of the PSYCHE-ICD study. J Psychosom Res. 2023;167:111182. https://doi.org/10.1016/j.jpsychores.2023.111182.

18.

•• Ghezzi ES, Sharman RLS, Selvanayagam JB, et al. Burden of mood symptoms and disorders in implantable cardioverter defibrillator patients: a systematic review and meta-analysis of 39 954 patients. Europace. 2023;25(6):euad130. https://doi.org/10.1093/europace/euad130. This recent meta-analysis provides the most comprehensive review of literature related to base rates of psychological distress in ICD patients.

19.

Spindler H, Johansen JB, Andersen K, Mortensen P, Pedersen SS. Gender differences in anxiety and concerns about the cardioverter defibrillator. Pacing Clin Electrophysiol. 2009;32(5):614–21. https://doi.org/10.1111/j.1540-8159.2009.02334.x.CrossRefPubMed

20.

Jacq F, Foulldrin G, Savouré A, et al. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients. Gen Hosp Psychiatry. 2009;31(3):266–73. https://doi.org/10.1016/j.genhosppsych.2009.01.003.CrossRefPubMed

21.

Tripp C, Huber NL, Kuhl EA, Sears SF. Measuring ICD shock anxiety: status update on the Florida Shock Anxiety Scale after over a decade of use. Pacing Clin Electrophysiol. 2019;42(10):1294–301. https://doi.org/10.1111/pace.13793.CrossRefPubMed

22.

• Sears SF, Rosman L, Sasaki S, et al. Defibrillator shocks and their effect on objective and subjective patient outcomes: results of the PainFree SST clinical trial. Heart Rhythm. 2018;15(5):734–40. https://doi.org/10.1016/j.hrthm.2017.12.026. This paper demonstrates the longitudinal impact of ICD shocks on patient activity levels and shock anxiety in a large international clinical trial.CrossRefPubMed

23.

Gallagher J, Murphy G, Caramlau I, et al. Device acceptance in ICD patients: shock anxiety, insomnia or both? J Card Fail. 2016;22(8). https://doi.org/10.1016/j.cardfail.2016.06.252.

24.

•• Lindekilde N, Skov O, Skovbakke SJ, Johansen JB, Nielsen JC, Pedersen SS. Anxiety and depression as risk factors for ICD shocks and mortality in patients with an implantable cardioverter defibrillator - a systematic review. Gen Hosp Psychiatry. 2022;78:96–107. https://doi.org/10.1016/j.genhosppsych.2022.07.008. The recent review highlights the lack of evidence for psychological distress as a trigger for ICD shocks. Relationships between distress and mortality are established however.CrossRefPubMed

25.

Ladwig KH, Baumert J, Marten-Mittag B, Kolb C, Zrenner B, Schmitt C. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study. Arch Gen Psychiatry. 2008;65(11):1324–30. https://doi.org/10.1001/archpsyc.65.11.1324.CrossRefPubMed

26.

• Schneider LM, Wong JJ, Adams R, et al. Posttraumatic stress disorder in pediatric patients with implantable cardioverter-defibrillators and their parents. Heart Rhythm. 2022;19(9):1524–9. https://doi.org/10.1016/j.hrthm.2022.06.025. This study provides base rates of PTSD in parents of children with ICDs.CrossRefPubMed

27.

Januszkiewicz Ł, Barra S, Marijon E, et al. Major gaps in the information provided to patients before implantation of cardioverter defibrillators: a prospective patient European evaluation. Europace. 2023;25(3):1144–51. https://doi.org/10.1093/europace/euac275.CrossRefPubMedPubMedCentral

28.

Edmondson D. An enduring somatic threat model of posttraumatic stress disorder due to acute life-threatening medical events. Soc Personal Psychol Compass. 2014;8(3):118–34. https://doi.org/10.1111/spc3.12089.CrossRefPubMedPubMedCentral

29.

Edmondson D, Birk JL, Ho VT, Meli L, Abdalla M, Kronish IM. A challenge for psychocardiology: addressing the causes and consequences of patients’ perceptions of enduring somatic threat. Am Psychol. 2018;73(9):1160–71. https://doi.org/10.1037/amp0000418.CrossRefPubMedPubMedCentral

30.

Presciutti AM, Bannon SM, Yamin JB, et al. The relationship between mindfulness and enduring somatic threat severity in long-term cardiac arrest survivors. J Behav Med. 2023;1–7. https://doi.org/10.1007/s10865-023-00405-x.

31.

Meli L, Alcántara C, Sumner JA, Swan B, Chang BP, Edmondson D. Enduring somatic threat perceptions and post-traumatic stress disorder symptoms in survivors of cardiac events. J Health Psychol. 2019;24(13):1817–27. https://doi.org/10.1177/1359105317705982.CrossRef

32.

Hofmann SG, Hay AC. Rethinking avoidance: toward a balanced approach to avoidance in treating anxiety disorders. J Anxiety Disord. 2018;55:14–21. https://doi.org/10.1016/j.janxdis.2018.03.004.CrossRefPubMedPubMedCentral

33.

Zhang X, Zhao Q, Wang M, Yang M, Fan X. Fear of movement and its associated psychosocial factors in heart failure patients: a cross-sectional study. Eur J Cardiovasc Nurs. 2023;22(3):273–81. https://doi.org/10.1093/eurjcn/zvac075.CrossRefPubMed

34.

Lemon J, Edelman S, Kirkness A. Avoidance behaviors in patients with implantable cardioverter defibrillators. Heart Lung. 2004;33(3):176–82. https://doi.org/10.1016/j.hrtlng.2004.02.005.CrossRefPubMed

35.

Cutitta KE, Woodrow LK, Ford J, et al. Shocktivity: ability and avoidance of daily activity behaviors in ICD patients. J Cardiopulm Rehabil Prev. 2014;34(4):241–7. https://doi.org/10.1097/HCR.0000000000000055.CrossRefPubMed

36.

Hammash M, McEvedy SM, Wright J, et al. Perceived control and quality of life among recipients of implantable cardioverter defibrillator. Aust Crit Care. 2019;32(5):383–90. https://doi.org/10.1016/j.aucc.2018.08.005.CrossRefPubMed

37.

Lee KS, Kim JH, Kang KW, Miller J, McEvedy SM, Hwang SY, Moser DK. Implantable cardioverter defibrillator shocks and psychological distress: examining the mediating roles of implantable cardioverter defibrillator–related concerns and perceived control. J Cardiovasc Nurs 2020;35(1):66–73. https://doi.org/10.1097/JCN.0000000000000610.

38.

Ichikura K, Kobayashi S, Matsuoka S, et al. Avoidance behavior associated with depressive symptoms in patients with implantable cardioverter defibrillators. Int J Clin Health Psychol. 2017;17(1):1–8. https://doi.org/10.1016/j.ijchp.2016.11.001.CrossRefPubMed

39.

Delle Donna P, Petrovic L, Nasir U, Ahmed A, Suero-Abreu GA. Phantom shocks associated with a wearable cardioverter defibrillator. J Med Cases. 2021;12(2):49–53. https://doi.org/10.14740/jmc3606.CrossRefPubMed

40.

Jacob S, Panaich SS, Zalawadiya SK, et al. Phantom shocks unmasked: clinical data and proposed mechanism of memory reactivation of past traumatic shocks in patients with implantable cardioverter defibrillators. J Interv Card Electrophysiol. 2012;34(2):205–13. https://doi.org/10.1007/s10840-011-9640-7.CrossRefPubMed

41.

Prudente LA. Phantom shock in a patient with an implantable cardioverter defibrillator: case report. Am J Crit Care. 2003;12(2):144–6.CrossRefPubMed

42.

Tea I, Caruso M, Tamer K, Kowey P. The shocking truth: phantom shocks as a manifestation of psychological problems associated with ICD insertion. J Am Coll Cardiol. 2018;71(11). https://doi.org/10.1016/s0735-1097(18)33074-2.

43.

Groh WJ, Foreman LD, Zipes DP. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators. Am Fam Physician. 1998;57(2):297–312.PubMed

44.

Prudente LA, Reigle J, Bourguignon C, Haines DE, DiMarco JP. Psychological indices and phantom shocks in patients with ICD. J Interv Card Electrophysiol. 2006;15(3):185–90. https://doi.org/10.1007/s10840-006-9010-z.CrossRefPubMed

45.

Varghese S, Geller JC, Ohlow MA. Phantom shocks in implantable cardioverter-defibrillator recipients: impact of education level, anxiety, and depression. Phantomschocks bei Patienten mit implantierbarem Kardioverter-Defibrillator: Einfluss von Bildungsniveau, Angst und Depression. Herzschrittmacherther Elektrophysiol. 2019;30(3):306–12. https://doi.org/10.1007/s00399-019-00645-y.

46.

Kohn CS, Petrucci RJ, Baessler C, Soto DM, Movsowitz C. The effect of psychological intervention on patients’ long-term adjustment to the ICD: a prospective study. Pacing Clin Electrophysiol. 2000;23(4 Pt 1):450–6. https://doi.org/10.1111/j.1540-8159.2000.tb00826.x.CrossRefPubMed

47.

Sears SF, Kovacs AH, Azzarello L, Larsen K, Conti JB. Innovations in health psychology: the psychosocial care of adults with implantable cardioverter defibrillators. Prof Psychol Res Pract. 2004;35(5):520–6. https://doi.org/10.1037/0735-7028.35.5.520.CrossRef

48.

Irvine J, Firestone J, Ong L, et al. A randomized controlled trial of cognitive behavior therapy tailored to psychological adaptation to an implantable cardioverter defibrillator. Psychosom Med. 2011;73(3):226–33. https://doi.org/10.1097/PSY.0b013e31820afc63.CrossRefPubMed

49.

Dougherty CM, Lewis FM, Thompson EA, Baer JD, Kim W. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;27(12):1594–602. https://doi.org/10.1111/j.1540-8159.2004.00691.x.CrossRefPubMed

50.

Ford J, Rosman L, Wuensch K, Irvine J, Sears SF. Cognitive-behavioral treatment of posttraumatic stress in patients with implantable cardioverter defibrillators: results from a randomized controlled trial. J Trauma Stress. 2016;29(4):388–92. https://doi.org/10.1002/jts.22111.CrossRefPubMed

51.

Ford J, Littleton H, Lutes L, et al. Evaluation of an Internet-based intervention for ICD patients with elevated symptoms of posttraumatic stress disorder. Pacing Clin Electrophysiol. 2019;42(5):521–9. https://doi.org/10.1111/pace.13654.CrossRefPubMed

52.

Schulz SM, Ritter O, Zniva R, et al. Efficacy of a web-based intervention for improving psychosocial well-being in patients with implantable cardioverter-defibrillators: the randomized controlled ICD-FORUM trial. Eur Heart J. 2020;41(11):1203–11. https://doi.org/10.1093/eurheartj/ehz134.CrossRefPubMed

53.

Berg SK, Rasmussen TB, Herning M, Svendsen JH, Christensen AV, Thygesen LC. Cognitive behavioural therapy significantly reduces anxiety in patients with implanted cardioverter defibrillator compared with usual care: Findings from the Screen-ICD randomised controlled trial. Eur J Prev Cardiol. 2020;27(3):258–68. https://doi.org/10.1177/2047487319874147.CrossRefPubMed

54.

Carroll AJ, Christon LM, Rodrigue JR, Fava JL, Frisch MB, Serber ER. Implementation, feasibility, and acceptability of quality of life therapy to improve positive emotions among patients with implantable cardioverter defibrillators. J Behav Med. 2020;43(6):968–78. https://doi.org/10.1007/s10865-020-00153-2.CrossRefPubMedPubMedCentral

55.

Habibović M, Denollet J, Cuijpers P, et al. Web-based distress management for implantable cardioverter defibrillator patients: a randomized controlled trial. Health Psychol. 2017;36(4):392–401. https://doi.org/10.1037/hea0000451.CrossRefPubMed

56.

Sall KE, Griffith AM, Midgette EP, et al. Cardiac psychology training in a rural health care setting: East Carolina Heart Institute. Health Psychol. 2022;41(10):803–12. https://doi.org/10.1037/hea0001167.CrossRefPubMed

57.

Burg MM, Stewart JC. If not us, who? If not now, when? Paths forward in science, patient care, and training to maximize the impact of cardiovascular behavioral medicine. Health Psychol. 2022;41(10):643–50. https://doi.org/10.1037/hea0001226.CrossRefPubMed

58.

Dekker J, Sears SF, Åsenlöf P, Berry K. Psychologically informed health care. Transl Behav Med. 2023;13(5):289–96. https://doi.org/10.1093/tbm/ibac105.CrossRefPubMedPubMedCentral

59.

Hauptman PJ, Chibnall JT, Guild C, Armbrecht ES. Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. JAMA Intern Med. 2013;173(7):571–7. https://doi.org/10.1001/jamainternmed.2013.3171.CrossRefPubMed

60.

Sears SF Jr, Conti JB. Quality of life and psychological functioning of icd patients. Heart. 2002;87(5):488–93. https://doi.org/10.1136/heart.87.5.488.CrossRefPubMedPubMedCentral

61.

Sears SE Jr, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol. 2003;26(3):107–11. https://doi.org/10.1002/clc.4960260303.CrossRefPubMed

62.

Sears SF, Hauf JD, Kirian K, Hazelton G, Conti JB. Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know. Circ Arrhythm Electrophysiol. 2011;4(2):242–50. https://doi.org/10.1161/CIRCEP.110.957670.CrossRefPubMed

63.

Sears SF Jr, Burns JL, Handberg E, Sotile WM, Conti JB. Young at heart: understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol. 2001;24(7):1113–7. https://doi.org/10.1046/j.1460-9592.2001.01113.x.CrossRefPubMed

64.

Ford J, Finch JF, Woodrow LK, et al. The Florida Shock Anxiety Scale (FSAS) for patients with implantable cardioverter defibrillators: testing factor structure, reliability, and validity of a previously established measure. Pacing Clin Electrophysiol. 2012;35(9):1146–53. https://doi.org/10.1111/j.1540-8159.2012.03455.x.CrossRefPubMed

65.

Eifert GH, Thompson RN, Zvolensky MJ, et al. The cardiac anxiety questionnaire: development and preliminary validity. Behav Res Ther. 2000;38(10):1039–53. https://doi.org/10.1016/s0005-7967(99)00132-1.CrossRefPubMed

66.

Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092–7. https://doi.org/10.1001/archinte.166.10.1092.CrossRefPubMed

67.

Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):509–15. https://doi.org/10.3928/0048-5713-20020901-06.CrossRef

68.

Burns JL, Serber ER, Keim S, Sears SF. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol. 2005;16(4):384–90. https://doi.org/10.1046/j.1540-8167.2005.40134.x.CrossRefPubMed

69.

Versteeg H, Starrenburg A, Denollet J, Palen Jv, Sears SF, Pedersen SS. Monitoring device acceptance in implantable cardioverter defibrillator patients using the Florida Patient Acceptance Survey. Pacing Clin Electrophysiol. 2012;35(3):283–93. https://doi.org/10.1111/j.1540-8159.2011.03299.x.

70.

Hirsh AT, Sears SF Jr, Conti JB. Cognitive and behavioral treatments for anxiety and depression in a patient with an implantable cardioverter defibrillator (ICD): a case report and clinical discussion. J Clin Psychol Med Settings. 2009;16(3):270–9. https://doi.org/10.1007/s10880-009-9160-0.CrossRefPubMedPubMedCentral

71.

Vicentini A, Bisignani G, De Vivo S, et al. Patient acceptance of subcutaneous versus transvenous defibrillator systems: a multi-center experience. J Cardiovasc Electrophysiol. 2022;33(1):81–9. https://doi.org/10.1111/jce.15297.CrossRefPubMed

72.

Timmermans I, Versteeg H, Meine M, Pedersen SS, Denollet J. Illness perceptions in patients with heart failure and an implantable cardioverter defibrillator: dimensional structure, validity, and correlates of the brief illness perception questionnaire in Dutch, French and German patients. J Psychosom Res. 2017;97:1–8. https://doi.org/10.1016/j.jpsychores.2017.03.014.CrossRefPubMed

73.

Sears SF, Sowell LD, Kuhl EA, et al. The ICD shock and stress management program: a randomized trial of psychosocial treatment to optimize quality of life in ICD patients. Pacing Clin Electrophysiol. 2007;30(7):858–64. https://doi.org/10.1111/j.1540-8159.2007.00773.x.CrossRefPubMed

74.

Hayes SC, Strosahl KD, Wilson KG. Acceptance and commitment therapy: the process and practice of mindful change. The Guilford Press; 2016.

75.

Bergman M, Keitel MA. At the heart of meaning-making: an acceptance and commitment approach to developing adaptive meaning following acute cardiac events. In: Navigating Life Transitions for Meaning. 2020;145–64. https://doi.org/10.1016/B978-0-12-818849-1.00009-6.

76.

Rashidi A, Whitehead L, Newson L, et al. The role of acceptance and commitment therapy in cardiovascular and diabetes healthcare: a scoping review. Int J Environ Res Public Health. 2021;18(15):8126. Published 2021 Jul 31. https://doi.org/10.3390/ijerph18158126.

77.

Dunbar SB, Dougherty CM, Sears SF, et al. Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation. 2012;126(17):2146–72. https://doi.org/10.1161/CIR.0b013e31825d59fd.CrossRefPubMed

78.

Hazelton AG, Sears SF, Kirian K, Matchett M, Shea J. Cardiology patient page. Coping with my partner’s ICD and cardiac disease. Circulation. 2009;120(10):e73–76. https://doi.org/10.1161/CIRCULATIONAHA.109.877613.

79.

• Dougherty CM, Thompson EA, Kudenchuk PJ. Patient plus partner trial: a randomized controlled trial of 2 interventions to improve outcomes after an initial implantable cardioverter-defibrillator. Heart Rhythm. 2019;16(3):453–9. https://doi.org/10.1016/j.hrthm.2018.10.011. This trial provides evidence of the importance of family and caregivers in the care of ICD patients.CrossRefPubMed

Titel: Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD
verfasst von: Sears S. F.
Harrell R.
Sorrell A.
Jordan E.
Anthony S.
Hashmath Z.
Nekkanti R.
Publikationsdatum: 24.07.2023
Verlag: Springer US
Erschienen in: Current Cardiology Reports / Ausgabe 9/2023
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-023-01924-4

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Addressing PTSD in Implantable Cardioverter Defibrillator Patients: State-of-the-Art Management of ICD Shock and PTSD

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2023

Efficacy of Bioactive Compounds in the Regulation of Metabolism and Pathophysiology in Cardiovascular Diseases

Venous Ethanol Ablation Approaches for Radiofrequency-Refractory Cardiac Arrhythmias

Correction to: Paradigm Shift in Diagnosis and Targeted Therapy in Recurrent Pericarditis

Fibrates, Hypertriglyceridemia, and CVD Risk: Where Do We Stand After the PROMINENT Trial for Triglyceride Lowering?

Pleiotropy of PCSK9: Functions in Extrahepatic Tissues

Update on Transcatheter Device Closure of Congenital Septal Defects

Neu im Fachgebiet Kardiologie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

Update Kardiologie